OCTOBER 3, 2019

Grants Awarded 

High impact grants awarded to Rogel Cancer Center members.
$100K+ Grants Awarded in August
NCI
Daniel Wahl, MD, PhD: K08 ($1.3M) “De Novo Nucleotide Synthesis as a Mediator of Radiation Resistance and a Therapeutic Target in Glioblastoma” (DT)
Other NIH
Mohammad Fallahi-Sichani, PhD: R35 ($1.8M) “Decoding the Logic of Cellular Signaling Through the Integration of Dynamic, Single-Cell and Multiplexed Methods” (CB)
Patrick O’Brien, PhD: R21 ($458K) “Cellular and Molecular Characterization of LIG1 Mutations Causing a Spectrum of Primary Immune Deficiencies” (CG)
Zhen Xu, PhD: R01 ($1.7M) “Transcranial Magnetic Resonance guided Histotripsy (tcMRgHt)” (DT)
Department of Defense
Richard Auchus, MD, PhD: $301K Translational Team Science Award (Partnering #1) for “Biomarker Development for Diagnosis, Surveillance, and Prognosis for Adrenocortical Carcinoma (ACC)” (DT)
Tobias Else, MD: $462K Translational Team Science Award (Partnering #2) for “Biomarker Development for Diagnosis, Surveillance, and Prognosis for Adrenocortical Carcinoma (ACC)” (CG)
Gary Hammer, MD, PhD: $794K Translational Team Science Award for “Biomarker Development for Diagnosis, Surveillance, and Prognosis for Adrenocortical Carcinoma (ACC)” (DT)
Gary Hammer, MD, PhD: $617K Idea Award with Special Focus for “Intra-Tumoral Steroid Production as a Mechanism of Immune Evasion in Adrenocortical Carcinoma (ACC)” (DT)
Breast Cancer Foundation
Debra Barton, PhD, RN: $213K continuation for “Enhancing Sexual Health in Female Cancer Survivors: Building a Personalized Biobehavioral Intervention” (HBO)
Sofia Merajver, MD, PhD: $250K continuation for “Targeting RhoC in Breast Cancer: Novel Drugs, Mathematical Models and Epidemiological Studies in North Africa” (TACR)
Lori Pierce, MD: $250K continuation for “Breast Cancer Cell Sensitivity to Radiotherapy in the Presence Of Targeted Therapies” (TACR)
James Rae, PhD: $250K continuation for “Pharmacogenomic Predictors of Breast Cancer Endocrine Response” (TACR)
Other External
Monika Burness, MD: $172K from Cyteir Therapeutics for “Pharmacologic Inhibition of RAD51 in Breast Cancer” (TACR)
Rajen Mody, MD: $200K 2019 Scholar Young Investigator Award from Hyundai Hope on Wheels for “Regulation of Alloimmune T-cell Function by Novel Long Intergenic Non-coding RNA Linc00402” (TACR)
Zhen Xu, PhD: $123K from the Focused Ultrasound Surgery Foundation for “Transcranial histotripsy for treatment of brain tumors - Initial In vivo Pig Study” (DT)
M-LINE 800-962-3555 | BLOG michiganhealthlab.org